Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Pemazyre 13.5 mg tablets {equilateral_black_triangle}

Active Ingredient:
pemigatinib
Company:  
Incyte Biosciences UK Ltd See contact details
ATC code: 
L01EN02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 12 Nov 2024

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Incyte Biosciences UK Ltd
Company image
Address
First Floor Q1, The Square, Randalls Way, Leatherhead, Surrey, KT22 7TW, UK
WWW
http://www.incyte.com
Telephone
+44 800 7833711
Medical Information Direct Line
00800 000 274 23
Medical Information e-mail
[email protected]